Obesity

Change in body mass index and disease burden among people with obesity and multiple long‐term conditions

Diabetes Obes MetabPublished Cohort study

Authors' conclusion

Weight loss in individuals with obesity and MLTCs was linked to both favourable and adverse outcomes, highlighting the importance of personalised treatment approaches that consider outcomes beyond weight loss.

Study context

Population
Adults aged ≤70 years with body mass index (BMI) ≥30 kg/m² and ≥2 obesity-related complications (ORCs); BMI recorded in Years 1 and 4 of baseline period; mean ORCs at index (Year 4) 3.8 (SD 1.5)
Participants
618,426 adults
Exposure
BMI change categories vs stable BMI
Outcome
Incident ORCs (risk of ≥1 new ORC), by BMI change category

Main finding

As reported in the abstract

HR (95% CI) for incident ORCs, highest BMI reduction

0.96

0.94–0.98

HR (95% CI) for incident ORCs, intermediate BMI reduction

0.98

0.96–0.99

HR (95% CI) for incident ORCs, lowest BMI reduction

0.98

0.97–0.99

Observational data: associations, not effects.

Further findings

Clinical consultations, by BMI reduction category

Risk ratio (95% CI) for consultations, highest BMI reduction
0.99 (0.98-1.00)
Risk ratio (95% CI) for consultations, intermediate BMI reduction
0.99 (0.98-1.00)
Risk ratio (95% CI) for consultations, lowest BMI reduction
1.00 (0.99-1.00)
  • Order as in the preceding sentence: highest to lowest BMI reductions

Polypharmacy

BMI reductions were linked to lower polypharmacy rates

Mental-health conditions, hospitalisation and mortality

Both BMI decrease and increase associated with higher HRs for mental-health conditions, hospitalisation and mortality vs stable BMI

Original publication

Change in body mass index and disease burden among people with obesity and multiple long‐term conditions. Diabetes Obes Metab. Published 12 January 2026. doi:10.1111/dom.70446

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.